Transplant drug preserves kidneys, avoids toxicity, studies suggest

March 14th, 2010 by Newspublichealth.com

The experimental drug belatacept can prevent graft rejection in kidney transplant recipients while better preserving kidney function when compared with standard immunosuppressive drugs, data from two international phase III clinical trials show.

Posted in Pharmacology | No Comments »
« Effort aims to spike breast cancer with new approach
Computer system helps reduce adverse drug side effects and interactions in ICU patients »
You can skip to the end and leave a response. Pinging is currently not allowed.

Leave a Reply

Sorry, no posts matched your criteria.